IT1317846B1 - Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. - Google Patents
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.Info
- Publication number
- IT1317846B1 IT1317846B1 IT2000MI000312A ITMI20000312A IT1317846B1 IT 1317846 B1 IT1317846 B1 IT 1317846B1 IT 2000MI000312 A IT2000MI000312 A IT 2000MI000312A IT MI20000312 A ITMI20000312 A IT MI20000312A IT 1317846 B1 IT1317846 B1 IT 1317846B1
- Authority
- IT
- Italy
- Prior art keywords
- drug
- chronic obstructive
- broncopneumopathy
- anticolinergic
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000MI000312A IT1317846B1 (it) | 2000-02-22 | 2000-02-22 | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
| AT01919303T ATE308317T1 (de) | 2000-02-22 | 2001-02-19 | Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung |
| PCT/EP2001/001833 WO2001062227A2 (en) | 2000-02-22 | 2001-02-19 | Anticholinergic drug formulations for treatment of chronic obstr uctive pulmonary disease |
| SI200130442T SI1257254T1 (sl) | 2000-02-22 | 2001-02-19 | Farmacevtske oblike, ki vsebujejo antiholinergicno zdravilo za zdravljenje kronicne obstruktivne bolezni pljuc |
| EP01919303A EP1257254B1 (en) | 2000-02-22 | 2001-02-19 | Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease |
| ES01919303T ES2249424T3 (es) | 2000-02-22 | 2001-02-19 | Formulaciones que contienen un farmaco anticolinergico para el tratamiento de bronconeumopatias cronicas obstructivas. |
| AU46450/01A AU776742B2 (en) | 2000-02-22 | 2001-02-19 | Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease |
| DE60114571T DE60114571T2 (de) | 2000-02-22 | 2001-02-19 | Formulierungen, enthaltend einen anticholinergen Wirkstoff für die Behandlung der chronisch obstruktiven pulmonalen Erkrankung |
| CA002400691A CA2400691A1 (en) | 2000-02-22 | 2001-02-19 | Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease |
| US10/204,307 US6964759B2 (en) | 2000-02-22 | 2001-02-19 | Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease |
| BR0108584-0A BR0108584A (pt) | 2000-02-22 | 2001-02-19 | Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva |
| DK01919303T DK1257254T3 (da) | 2000-02-22 | 2001-02-19 | Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom |
| JO200126A JO2381B1 (en) | 2000-02-22 | 2001-02-20 | Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000MI000312A IT1317846B1 (it) | 2000-02-22 | 2000-02-22 | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI20000312A0 ITMI20000312A0 (it) | 2000-02-22 |
| ITMI20000312A1 ITMI20000312A1 (it) | 2001-08-22 |
| IT1317846B1 true IT1317846B1 (it) | 2003-07-15 |
Family
ID=11444121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT2000MI000312A IT1317846B1 (it) | 2000-02-22 | 2000-02-22 | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6964759B2 (it) |
| EP (1) | EP1257254B1 (it) |
| AT (1) | ATE308317T1 (it) |
| AU (1) | AU776742B2 (it) |
| BR (1) | BR0108584A (it) |
| CA (1) | CA2400691A1 (it) |
| DE (1) | DE60114571T2 (it) |
| DK (1) | DK1257254T3 (it) |
| ES (1) | ES2249424T3 (it) |
| IT (1) | IT1317846B1 (it) |
| JO (1) | JO2381B1 (it) |
| WO (1) | WO2001062227A2 (it) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
| DZ2947A1 (fr) * | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
| US6315985B1 (en) * | 1999-06-18 | 2001-11-13 | 3M Innovative Properties Company | C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability |
| IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
| IT1317720B1 (it) * | 2000-01-07 | 2003-07-15 | Chiesi Farma Spa | Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani. |
| IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
| IT1318514B1 (it) * | 2000-05-12 | 2003-08-27 | Chiesi Farma Spa | Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. |
| US20060257324A1 (en) | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
| CA2411047C (en) | 2000-05-22 | 2009-08-04 | Chiesi Farmaceutici S.P.A. | Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| SI1273292T1 (en) * | 2001-07-02 | 2004-12-31 | Chiesi Farmaceutici S.P.A. | Optimised formulation of tobramycin for aerosolization |
| EP1321159A1 (en) * | 2001-12-21 | 2003-06-25 | CHIESI FARMACEUTICI S.p.A. | Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices |
| US7255102B2 (en) * | 2002-02-01 | 2007-08-14 | Generex Pharmaceuticals Inc. | Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin |
| EP1340492A1 (en) * | 2002-03-01 | 2003-09-03 | CHIESI FARMACEUTICI S.p.A. | Aerosol formulations for pulmonary administration of medicaments having systemic effects |
| ATE465712T1 (de) * | 2002-03-01 | 2010-05-15 | Chiesi Farma Spa | Ultrafeine zusammensetzungen von formoterol |
| EP1415647A1 (en) * | 2002-10-23 | 2004-05-06 | CHIESI FARMACEUTICI S.p.A. | "Long-acting beta-2 agonists ultrafine formulations" |
| DE10214263A1 (de) * | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum |
| US20040102469A1 (en) * | 2002-09-13 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for reducing the mortality rate |
| WO2005037949A2 (en) | 2003-10-07 | 2005-04-28 | Chrysalis Technologies Incorporated | Aerosol formulations of butalbital, lorazepam, ipratropium, baclofen, morphine and scopolamine |
| EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
| EP1807122A4 (en) * | 2004-09-24 | 2009-04-22 | 3M Innovative Properties Co | MEDICAL AEROSOL FORMULATIONS AND METHOD FOR SYNTHETIZING INGREDIENTS THEREFOR |
| DE102006023770A1 (de) * | 2006-05-20 | 2007-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Treibgasfreie Aerosolformulierung für die Inhalation |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| US10011906B2 (en) | 2009-03-31 | 2018-07-03 | Beohringer Ingelheim International Gmbh | Method for coating a surface of a component |
| EP2432531B1 (de) | 2009-05-18 | 2019-03-06 | Boehringer Ingelheim International GmbH | Adapter, inhalationseinrichtung und zerstäuber |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| TWI707700B (zh) | 2009-05-29 | 2020-10-21 | 美商沛爾醫療股份有限公司 | 用於經由肺部遞送長效蕈毒鹼拮抗劑及長效β2腎上腺素受體激動劑之組成物，及相關方法及系統 |
| EP2501363B1 (en) * | 2009-11-17 | 2015-01-14 | Cipla Limited | Inhalation solutions |
| AP3141A (en) | 2009-11-25 | 2015-02-28 | Boehringer Ingelheim Int | Nebulizer |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
| US9943654B2 (en) | 2010-06-24 | 2018-04-17 | Boehringer Ingelheim International Gmbh | Nebulizer |
| EP2694220B1 (de) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| CA2905542C (en) | 2013-03-15 | 2022-05-03 | Pearl Therapeutics, Inc. | Methods and systems for conditioning of particulate crystalline materials |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| EP3030298B1 (en) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nebulizer |
| US20170216286A1 (en) | 2014-01-28 | 2017-08-03 | Mayo Foundation For Medical Education And Research | Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid |
| US10328058B2 (en) | 2014-01-28 | 2019-06-25 | Mayo Foundation For Medical Education And Research | Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques |
| CN110623956A (zh) | 2014-01-28 | 2019-12-31 | 巴克老龄化研究所 | 用于杀死衰老细胞和用于治疗衰老相关疾病和病症的方法和组合物 |
| JP6580070B2 (ja) | 2014-05-07 | 2019-09-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 容器、ネブライザ、及び使用 |
| WO2015169430A1 (en) | 2014-05-07 | 2015-11-12 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2015169429A2 (en) | 2014-05-07 | 2015-11-12 | Boehringer Ingelheim International Gmbh | Container, indicator device, and nebulizer |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3361306A (en) | 1966-03-31 | 1968-01-02 | Merck & Co Inc | Aerosol unit dispensing uniform amounts of a medically active ingredient |
| US3622053A (en) | 1969-12-10 | 1971-11-23 | Schering Corp | Aerosol inhaler with flip-up nozzle |
| MX3864E (es) | 1975-05-27 | 1981-08-26 | Syntex Corp | Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona |
| US4185100A (en) | 1976-05-13 | 1980-01-22 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
| US4499108A (en) | 1983-06-08 | 1985-02-12 | Schering Corporation | Stable pleasant-tasting albuterol sulfate pharmaceutical formulations |
| IT1196142B (it) | 1984-06-11 | 1988-11-10 | Sicor Spa | Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti |
| US5192528A (en) | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
| US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| GB8828477D0 (en) | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
| IL97065A (en) | 1990-02-02 | 1994-01-25 | Fisons Plc | Repellent preparations for aerosol |
| AU8642391A (en) | 1990-12-19 | 1992-07-22 | Smithkline Beecham Corporation | Aerosol formulations |
| US6006745A (en) * | 1990-12-21 | 1999-12-28 | Minnesota Mining And Manufacturing Company | Device for delivering an aerosol |
| EP0504112A3 (en) | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
| DE69227189T2 (de) | 1991-05-21 | 1999-02-25 | Abbott Laboratories, Abbott Park, Ill. | Aerosolinhalationsvorrichtung |
| CZ282972B6 (cs) | 1991-08-29 | 1997-11-12 | Broncho-Air Medizintechnik Ag | Lékařský přístroj pro inhalování dávkovaných aerosolů |
| IL103238A (en) | 1991-09-25 | 1995-07-31 | Fisons Plc | Pressurised aerosol compositions |
| IL104068A (en) | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
| ATE260641T1 (de) | 1991-12-18 | 2004-03-15 | Minnesota Mining & Mfg | Aerosolzusammensetzungen für arzneimittelsuspensionen |
| DE4230876A1 (de) | 1992-03-17 | 1993-09-23 | Asta Medica Ag | Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten |
| SK280911B6 (sk) | 1992-12-09 | 2000-09-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Farmaceutický prostriedok |
| SE9203743D0 (sv) | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
| AU4066693A (en) | 1992-12-23 | 1994-07-19 | Bernhard Hugemann | Compacted drug body for use in the mechanical generation of inhalable active-substance particles |
| AU679511B2 (en) | 1993-03-17 | 1997-07-03 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
| NZ263410A (en) | 1993-03-17 | 1997-05-26 | Minnesota Mining & Mfg | Pharmaceutical aerosol containing diol-diacid derived dispersing aid |
| US6596260B1 (en) | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
| AU680967B2 (en) | 1993-12-20 | 1997-08-14 | Minnesota Mining And Manufacturing Company | Flunisolide aerosol formulations |
| GB9425160D0 (en) | 1994-12-10 | 1995-02-08 | Glaxo Group Ltd | Medicaments |
| EE9700138A (et) | 1994-12-22 | 1997-12-15 | Astra Aktiebolag | Aerosoolravimvormid |
| GB9426252D0 (en) | 1994-12-24 | 1995-02-22 | Glaxo Group Ltd | Pharmaceutical composition |
| DE4446891A1 (de) | 1994-12-27 | 1996-07-04 | Falk Pharma Gmbh | Stabile wäßrige Budesonid-Lösung |
| US5653961A (en) * | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
| DE69631476T2 (de) | 1995-04-14 | 2005-01-13 | Smithkline Beecham Corp. | Vorrichtung zur dosierten inhalierung von beclomethason-diproprionat |
| RO119116B1 (ro) * | 1995-04-14 | 2004-04-30 | Glaxo Wellcome Inc. | Inhalator pentru dozarea salmeterolului |
| NZ306278A (en) | 1995-04-14 | 1999-07-29 | Glaxo Wellcome Inc | Metered dose aerosol inhaler with internal surfaces coated with fluorocarbon polymers for delivering of albuterol (also known as salbutamol) |
| HU219899B (hu) * | 1995-04-14 | 2001-09-28 | Glaxo Wellcome Inc. | Inhalálóberendezés flutikaszon-propionát adagolására mért dózisban |
| GB9612297D0 (en) | 1996-06-11 | 1996-08-14 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
| WO1998001147A1 (en) | 1996-07-08 | 1998-01-15 | Rhone-Poulenc Rorer Limited | Medicinal cyclosporin-a aerosol solution formulation |
| AU3811897A (en) | 1996-07-24 | 1998-02-10 | Oglios Therapeutics, Inc. | Antisense oligonucleotides as antibacterial agents |
| GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
| GB9620187D0 (en) | 1996-09-27 | 1996-11-13 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
| US6413496B1 (en) * | 1996-12-04 | 2002-07-02 | Biogland Ireland (R&D) Limited | Pharmaceutical compositions and devices for their administration |
| ATE301991T1 (de) | 1996-12-04 | 2005-09-15 | Link Products Ltd | Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung |
| US6461591B1 (en) | 1997-02-05 | 2002-10-08 | Jago Research Ag | Medical aerosol formulations |
| US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| US5891419A (en) | 1997-04-21 | 1999-04-06 | Aeropharm Technology Limited | Environmentally safe flunisolide aerosol formulations for oral inhalation |
| US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
| GB2326334A (en) * | 1997-06-13 | 1998-12-23 | Chiesi Farma Spa | Pharmaceutical aerosol compositions |
| BR7702049U (pt) | 1997-09-05 | 1999-09-14 | Chiesi Farma Spa | Bico pulverizador para utilização em inalador oral para medicamentos aerossóis |
| NZ504021A (en) | 1997-10-17 | 2003-04-29 | Systemic Pulmonary Delivery Lt | Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication |
| US6045784A (en) | 1998-05-07 | 2000-04-04 | The Procter & Gamble Company | Aerosol package compositions containing fluorinated hydrocarbon propellants |
| SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
| NZ509418A (en) | 1998-06-18 | 2003-06-30 | Boehringer Ingelheim Pharma | Pharmaceutical formulations for aerosols with two or more active substances |
| US6451285B2 (en) | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
| US6241969B1 (en) | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| JP4570251B2 (ja) | 1998-07-24 | 2010-10-27 | ヤゴテック アーゲー | 医薬用エーロゾル製剤 |
| US6475467B1 (en) | 1998-08-04 | 2002-11-05 | Jago Research Ag | Medicinal aerosol formulations |
| DE19847969A1 (de) | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Lagerfähig flüssige Formulierung mit Formoterol |
| EA003960B1 (ru) | 1998-10-17 | 2003-10-30 | Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг | Устойчивый при хранении концентрат биологически активного вещества формотерола |
| DE59914603D1 (de) * | 1998-11-13 | 2008-02-14 | Jagotec Ag | Multidosis-Trockenpulverinhalator mit Pulverreservoir |
| DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
| US6004537A (en) | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| US6290930B1 (en) | 1998-12-18 | 2001-09-18 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide |
| HUP0200185A3 (en) | 1999-03-05 | 2006-07-28 | Chiesi Farma Spa | Improved powdery pharmaceutical compositions for inhalation |
| US6315985B1 (en) | 1999-06-18 | 2001-11-13 | 3M Innovative Properties Company | C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability |
| WO2001047493A1 (en) | 1999-12-24 | 2001-07-05 | Glaxo Group Limited | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
| IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
| US20030190278A1 (en) * | 2002-04-08 | 2003-10-09 | Yan Mei Wang | Controlled deposition of nanotubes |
-
2000
- 2000-02-22 IT IT2000MI000312A patent/IT1317846B1/it active
-
2001
- 2001-02-19 WO PCT/EP2001/001833 patent/WO2001062227A2/en active IP Right Grant
- 2001-02-19 AT AT01919303T patent/ATE308317T1/de not_active IP Right Cessation
- 2001-02-19 CA CA002400691A patent/CA2400691A1/en not_active Abandoned
- 2001-02-19 DE DE60114571T patent/DE60114571T2/de not_active Expired - Fee Related
- 2001-02-19 BR BR0108584-0A patent/BR0108584A/pt not_active Application Discontinuation
- 2001-02-19 AU AU46450/01A patent/AU776742B2/en not_active Ceased
- 2001-02-19 US US10/204,307 patent/US6964759B2/en not_active Expired - Fee Related
- 2001-02-19 EP EP01919303A patent/EP1257254B1/en not_active Expired - Lifetime
- 2001-02-19 DK DK01919303T patent/DK1257254T3/da active
- 2001-02-19 ES ES01919303T patent/ES2249424T3/es not_active Expired - Lifetime
- 2001-02-20 JO JO200126A patent/JO2381B1/en active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1257254B1 (en) | 2005-11-02 |
| DE60114571T2 (de) | 2006-06-08 |
| ATE308317T1 (de) | 2005-11-15 |
| DE60114571D1 (de) | 2005-12-08 |
| BR0108584A (pt) | 2003-03-25 |
| WO2001062227A3 (en) | 2002-03-07 |
| ITMI20000312A0 (it) | 2000-02-22 |
| US6964759B2 (en) | 2005-11-15 |
| US20030157028A1 (en) | 2003-08-21 |
| WO2001062227A2 (en) | 2001-08-30 |
| DK1257254T3 (da) | 2006-03-20 |
| AU776742B2 (en) | 2004-09-23 |
| JO2381B1 (en) | 2006-12-12 |
| CA2400691A1 (en) | 2001-08-30 |
| AU4645001A (en) | 2001-09-03 |
| ITMI20000312A1 (it) | 2001-08-22 |
| EP1257254A2 (en) | 2002-11-20 |
| ES2249424T3 (es) | 2006-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1317846B1 (it) | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. | |
| CY1122027T1 (el) | Υπερλεπτο σκευασμα φορμοτερολης | |
| HUS1800032I1 (hu) | Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére | |
| HUP0402487A2 (hu) | Dózist adagoló inhaláló készülék | |
| ATE341309T1 (de) | Pulmonale arzneistoffverabreichung | |
| BR9915095A (pt) | Composição farmacêutica ministrável em aerosol | |
| MY131733A (en) | Aerosol drug formulations | |
| ID29181A (id) | Kombinasi formoterol dan garam tiotropium | |
| HUP0102468A2 (hu) | Nyomás alatti dózisadagoló inhaláló berendezés és aeroszol formájú gyógyászati készítmények | |
| ATE342053T1 (de) | Formulierungen zur inhalation | |
| DE60019167D1 (de) | Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason | |
| SE0102276D0 (sv) | Device and method for the administration of a medicament | |
| JO2506B1 (en) | Dosage titration device in hydrofluoroalkan propellants | |
| BG107257A (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
| TNSN07289A1 (en) | Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent | |
| AU2003215588A1 (en) | Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery | |
| DE60017450D1 (de) | Pharmazeutische formulierungen enthaltend salmeterol | |
| TH51588A (th) | สูตรผสมที่มียาแอนตีโคลิเนอจิก สำหรับการรักษาของโรคการอุดตันของปอดชนิดเรื้อรัง |